Overview Financials News + Filings Key Docs Charts Transactions Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Appointed COO
Appointed director
|
|
BridgeBio Pharma, Inc. (BBIO)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/03/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 05/04/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 11/03/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 08/04/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
| 05/05/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
| 11/04/2021 |
10-Q
| Quarterly Report for the period ended September 30, 2021 |
| 08/05/2021 |
10-Q
| Quarterly Report for the period ended June 30, 2021 |
| 05/06/2021 |
10-Q
| Quarterly Report for the period ended March 31, 2021 |
| 11/05/2020 |
10-Q
| Quarterly Report for the period ended September 30, 2020 |
| 08/11/2020 |
10-Q
| Quarterly Report for the period ended June 30, 2020 |
| 11/08/2019 |
10-Q
| Quarterly Report for the period ended September 30, 2019 |
| 08/14/2019 |
10-Q
| Quarterly Report for the period ended June 30, 2019 |
|
|